Companies: 10,795·Total market cap: $144.5T
Noxopharm Limited

Noxopharm Limited

NOXOFOTCHealthcare
$0.05
+$0.00(+0.00%)
Market Cap$14781601
P/E Ratio—
52W High$0.045
52W Low$0.045
Shares OutstandingFinancialsRevenue

Noxopharm Limited (NOXOF) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

NOXOF · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
292.3M▲ +0.01% YoY Change
FY · as of Jun 30, 2024 · Reported in AUD
vs 292.2M in FY 2023
Diluted Shares Outstanding
292.2M
incl. options, RSUs, convertibles
Dilution Spread
+-0.01%
Diluted vs Basic
YoY Change
+0.01%
year-over-year
Float (Free Float)
195.5M
publicly tradable shares
59.5% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+3.5%
2021 → 2024
5-Year CAGRincreasing
+16.2%
2019 → 2024
10-Year CAGR—
—
—
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2024Latest
Diluted Shares: 292.2M
292.3M
+0.01%
FY 2023
Diluted Shares: 292.2M
292.2M
+0.35%
FY 2022
Diluted Shares: 291.2M
291.2M
+10.37%
FY 2021
Diluted Shares: 263.9M
263.9M
+90.70%
FY 2020
Diluted Shares: 138.4M
138.4M
+0.15%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs NOXOF
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+756.1%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+731.0%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+509.2%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+430.4%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+211.4%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+207.3%
#7
Noxopharm LimitedNOXOF
Noxopharm LimitedYOU
292.3M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Noxopharm Limited (NOXOF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of June 30, 2024, Noxopharm Limited reports 292.3M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Noxopharm Limited's basic shares outstanding (292.3M) represents currently issued shares. Diluted shares outstanding (292.2M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +-0.01%.

Shares Outstanding vs. Float (Free Float)

Noxopharm Limited's float is 195.5M (59.5% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float195.5M(59.5%)
Outstanding328.5M

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · AUD

About shares outstanding & methodology

Noxopharm Limited (NOXOF) shares outstanding history from 2016 to 2024. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Noxopharm Limited shares outstanding for the fiscal year ending June 30, 2024 were 292.3M, a 0.01% increase year-over-year. Noxopharm Limited FY 2024 shares outstanding were 292.3M, a +0.01% increase from FY 2023.

Noxopharm Limited is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

NOXOF shares outstanding · 4 questions

As of June 30, 2024, Noxopharm Limited (NOXOF) has approximately 292.3M basic shares outstanding and 292.2M diluted shares outstanding. This represents a +0.01% year-over-year increase from FY 2023 (292.2M). The increase may reflect equity compensation issuances or secondary offerings.

NOXOF shares outstandinghow many shares does NOXOF haveNOXOF basic shares 2024NOXOF diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Noxopharm Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08